Anemia is probably one of the most well-known toxic effects of lead. Previously, lead-induced anemia was considered to be from the inhibition of d-aminolevulinic acid dehydratase participating in the heme biosynthesis. However, little is known whether lead could affect the destruction of erythrocyte, another important factor for anemia. In the present study, we demonstrated that lead could accelerate the splenic sequestration of erythrocytes through phosphatidylserine (PS) exposure and subsequently increased erythrophagocytosis. In freshly isolated human erythrocytes, Pb 21 -induced PS exposure at relatively low concentrations (~0.1mM) by inhibiting flippase, a key aminophospholipid translocase for the maintenance of PS asymmetry and adenosine triphosphate depletion appeared to underlie this phenomenon. Abnormal shape changes of erythrocytes and microvesicle generation and other triggers for the erythrophagocytosis were also observed in the Pb 21 -exposed erythrocytes. In vitro data showed that human macrophage indeed recognized and phagocytosis PS-exposed erythrocytes. In good accordance with these in vitro results, the oral administration of Pb 21 increased PS exposure on erythrocytes in rat in vivo. In addition, reduction of hematocrit and hemoglobin and increased spleen weight were observed along with enhanced splenic sequestration of erythrocytes in the rats exposed to Pb 21 subchronically for 4 weeks through drinking water. In conclusion, these results suggest that Pb 21 -induced anemia may be explained at least in part by increased PS exposure on erythrocytes, erythrophagocytosis, and splenic sequestration.
Lead has second ranked in the list of hazardous substances for several years (ATSDR, 2007) , indicating its importance as an environmental toxicant. Lead pollution mostly comes from modern industrialization and human activities. Diverse sources of lead pollution are identified including factories, mining (Stohs and Bagchi, 1995) , leaded paints, leaded gasoline, and lead-contaminated drinking water (Zietz et al., 2010) . Lead afflicts varying degree of toxicity to many tissues and organs including nervous, renal, and cardiovascular systems at submicromolar concentrations (<10 lg/dl) (Goyer and Clarkson, 2001) . Especially, children and pregnant woman are vulnerable to even lower lead concentrations. In this background, lead contamination is strictly regulated, and the Center for Disease Control (CDC) defines lead poisoning as the blood lead level (BLL) exceeding 10 lg/dl (0.5l M) (CDC, 1997) .
Lead exposure comes mostly from oral ingestion and oral bioavailability was determined to be around 37-70% through radiotracer experiments (James et al., 1985; Rabinowitz et al., 1980) . Lead distributes into three major compartments in the body: bone, blood, and soft tissues. Of lead reaching systemic circulation, blood lead accounts for about 90% of total body lead burden after acute exposure and more than 95% of blood lead is accumulated in erythrocytes. Therefore, erythrocytes are regarded as an early and primary victim to lead-induced toxicity in the cardiovascular system. In accordance with this, the most well-known hematological toxicity of lead is anemia. Anemia is an abnormal decrease in the hematocrit or hemoglobin. Chemical-induced anemia may be caused by impaired erythrocyte production in the bone marrow or excessive erythrocyte destruction in the spleen or liver. It is well established that lead interferes with heme biosynthesis (Hutchison and Start, 1961) through the inhibition of d-aminolevulinic acid dehydratase (ALAD) and ferrochelatase that are critical to the heme synthesis (Ku et al., 1990; Liao et al., 2008) . However, little is known if lead could induce excessive erythrocytes destruction.
Erythrocytes can be removed by direct hemolysis or erythrophagocytosis. Paglia et al. (1975) and Valentine et al. (1976) suggested the inhibitory activities of lead against erythrocyte pyrimidine 5#nucleotidase as the mechanism underlying the lead-induced hemolytic anemia. However, there is no report on the effect of lead on erythrophagocytosis, another important pathway for erythrocyte destruction to our best knowledge. Erythrophagocytosis is the main route of normal and pathophysiological clearance of damaged erythrocytes (Otogawa et al., 2007; Waitumbi et al., 2000) . Tissue macrophages in the reticuloendothelial system of spleen and liver recognize abnormal erythrocytes through various mechanisms. Erythrocytes with reduced deformability or abnormal shapes could be easily engulfed by macrophages (Fens et al., 2010) . Recent interests are given to the role of phosphatidylserine (PS) exposure on erythrocytes in the erythrophagocytosis (Kobayashi et al., 2007; Noh et al., 2010) . PS, normally retained on the inner leaflet, becomes externalized to the outer membrane when exposed to various stimuli. PS on the outer membrane of erythrocytes is recognized by tissue macrophages as a signal for phagocytosis. In addition, PS-bearing microvesicles (MVs) which are released from PS exposing erythrocytes can be engulfed by macrophages.
In the present study, we discovered that low concentrations of lead (Pb 2þ ) induce PS exposure and MV generation in freshly isolated human erythrocytes. We elucidated the mechanism underlying and investigated if lead-induced PS exposure in erythrocytes can trigger phagocytosis and contribute to accelerated clearance by spleen and liver, employing in vitro and in vivo models in an effort to give a new insight into lead-induced anemia.
MATERIALS AND METHODS

Chemicals
Lead(II) acetate, calcium chloride, glutaraldehyde solution, osmium tetroxide, calcium ionophore A23187, bovine serum albumin (BSA), N-[2-hydroxyethyl]-piperazine-N#-[2-ethanesulfonic acid] (HEPES), sodium citrate, dimethyl sulfoxide, trichloroacetic acid (TCA), Tris-base, Tris-acetate, poly-L-lysine, adenosine triphosphate (ATP) bioluminescent assay kit, phorbol 12-myristate 13-acetate (PMA) were obtained from Sigma Chemical Co. (St Louis, MO). 1-Palmitoyl-2-[6-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]caproyl]-sn-glycero-3-phosphoserine (C 6 -NBD-PS) and 1-oleoyl-2-[6-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]hexanoyl]-sn-glycero-3-phosphocholine (C 6 -NBD-PC) were purchased from Avanti Polar Lipids (Alabaster, AL). Phycoerythrin-labeled monoclonal antibody against human glycophorin A (anti-glycophorin A-RPE) was from Dako (Glostrub, Denmark) and fluo-4 acetoxymethyl ester (Fluo-4 AM) was from Molecular Probes (Eugene, OR). Fluorescein isothiocyanate (FITC)-labeled annexin V (annexin V-FITC) was from Pharmingen (San Diego, CA). 5-(and-6)-Carboxyfluorescein diacetate (CFDA) were obtained from Invitrogen (Eugene, OR). RPMI 1640, Dulbecco's Phosphate Buffered Saline, penicillin/streptomycin, and fetal bovine serum were purchased from Gibco BRL Life Technologies Inc. (Grand Island, NY).
Preparation of Erythrocytes
With an approval from the Ethics Committee of Health Service Center at Seoul National University, human blood was obtained from healthy male donors (18-25 years old) using a vacutainer with acid citrate dextrose and a 21-gauge needle (Becton Dickinson, Franklin Lakes, NJ) on the day of each experiment. Plateletrich plasma and buffy coat were removed by aspiration after centrifugation at 300 3 g for 15 min. Packed erythrocytes were washed three times with sterilized PBS (1mM KH 2 PO 4 , 154mM NaCl, 3mM Na 2 HPO 4 , pH 7.4) and once with filtersterilized Ringer's solution (125mM NaCl, 5mM KCl, 1mM MgSO 4 , 32mM HEPES, 5mM glucose, pH 7.4). Washed erythrocytes were resuspended in Ringer's solution to a cell concentration of 5 3 10 7 cells/ml and final CaCl 2 concentration was adjusted to 1mM prior to use.
Flow Cytometric Analysis of PS Exposure and MV Generation
After erythrocytes were treated with deionized water (DW) (vehicle) or Pb 2þ for 24 h at 37°C, aliquots of blood samples were diluted 10-fold with annexinbinding buffer (125mM NaCl, 10mM HEPES, pH 7.4) and further incubated with following substances for 30 min at room temperature in dark. Annexin V-FITC was used as a marker for PS detection, whereas anti-glycophorin A-RPE was used as an identifier of erythrocytes and erythrocyte-derived MVs. Negative controls for annexin V binding were stained with annexin V-FITC in the presence of EDTA instead of CaCl 2 adjusted to final 2.5mM. Samples were analyzed on the flow cytometer FACScalibur (Becton Dickinson, San Jose, CA) equipped with argon ion laser emitting at 488 nm. The light scatter and fluorescence channels were set on log scale. Data from 10,000 events were collected and analyzed using CellQuest Pro software.
Microscopic Observation Using Scanning Electron Microscopy and Confocal Microscopy
After fixation with 2% glutaraldehyde solution for 1 h at 4°C, the erythrocytes were centrifuged and washed three times with PBS and followed by post-fixation with 1% osmium tetroxide for 30 min at room temperature. After washing with PBS several times, the samples were dehydrated serially with 50, 70, 90, and 100% ethanol. After drying and coating with gold, the images were observed on scanning electron microscope (JEOL, Tokyo, Japan). For confocal microscopy, 200 l of erythrocytes suspension was added and attached for 1 h to 8-chambered coverslip (NUNC, Rosklide, Denmark), which has been coated with 0.1 mg/ml poly-L-lysine. After washing coverslip three times with Ringer's solution containing 2% BSA, erythrocytes were stained with Ringer's solution containing anti-glycophorin A-FITC for 30 min and washed three times again. Then, erythrocytes were incubated with vehicle (Ringer's solution) or Pb 2þ and then observed using confocal microscopy equipped with argon laser (Leica, Wetzlar, Germany). Excitation and emission filters were set at 488 and 550-600 nm, respectively.
Measurement of Phospholipid Translocation
Phospholipid translocation was measured according to the methods previously described (Hilarius et al., 2004) . Briefly, erythrocytes (5 3 10 7 cells/ml) were incubated with Pb 2þ and then loaded with 0.5lM C 6 -NBD-PS or C 6 -NBD-PC. Aliquots from the cell suspension were removed at the indicated time intervals and placed on ice-cold Ringer's solution for 10 min in the presence or absence of 1% BSA, respectively. The amount of internalized probe was determined by comparing the fluorescence intensity associated with the cells before and after back-extraction. Samples were analyzed on the flow cytometer FACScalibur (Becton Dickinson).
Measurement of Intracellular ATP Level
After incubation with lead, erythrocytes were washed and resuspended in Ringer's solution containing 1mM CaCl 2 . The aliquot was mixed vigorously with 10% TCA solution and TAE buffer (100mM Tris-acetate, 2mM EDTA, pH 7.8) and then cooled in ice for 20 min. The sample was centrifuged and the aliquot of resultant supernatant was mixed with cold TAE buffer. Samples were adapted to luciferin/luciferase assay in Luminoskan (Labsystems, Franklin, MA) using an ATP assay kit (Sigma).
Measurement of Intracellular Calcium Level
For detecting intracellular calcium increase, erythrocytes were loaded with 3lM Fluo-4 AM for 1 h at 37°C in the dark. Subsequently, the cells were washed twice and then resuspended in Ringer's solution to a final concentration of 5 3 10 7 cells/ml with 1mM of CaCl 2 . After erythrocytes were incubated with 178 JANG ET AL.
Pb 2þ for 4 h at 37°C, samples were analyzed on the flow cytometer FACScalibur (Becton Dickinson). Data from 10,000 events were collected and analyzed using CellQuest Pro software.
Measurement of In Vitro Erythrophagocytosis
Human leukemia cell lines, THP-1, were purchased from the American Type Culture Collection (Manassas, VA) and maintained in RPMI 1640 supplemented with 10% heat-inactivated fetal bovine serum and 1% penicillin/streptomycin at 37°C under 5% CO 2 atmosphere. THP-1 cells were prepared as described by Dasgupta et al. (2008) . THP-1 cells were cultured (1 3 10 6 cells per well) in 60 cm 2 dish overnight with PMA 600 ng/ml to differentiate to macrophage, followed by coincubation for 18 h with vehicle-or Pb 2þ -treated human erythrocytes (2 3 10 7 cells per well) and then observed under phase contrast microscopy (Olympus IX70, Japan). For coincubation with macrophages, chemical-treated erythrocytes were washed and resuspended with RPMI 1640. For flow cytometric analysis, erythrocytes were loaded with 10lM of CFDA for 30 min before coincubation. After the coincubation, macrophages were harvested and washed several times to remove unattached erythrocytes. Samples were analyzed on the flow cytometer FACScalibur (Becton Dickinson). Data from 10,000 events were collected and analyzed using CellQuest Pro software.
In Vivo Experiments
Detection of PS exposure following lead administration in rats. All the protocols used in vivo experiments were approved by the Ethics Committee of Animal Service Centre at Seoul National University. Male Sprague-Dawley rats (Samtako Co., Korea) weighing 200-250 g were used in all experiments. Before the experiments, animals were acclimated for 1 week. Food and water were provided ad libitum. At the time of experiment, rats were randomly grouped for control (DW), 10, and 50 mg/kg of Pb 2þ doses. Four hours after lead was administered per oral, blood was collected from the abdominal aorta using 3.8% trisodium citrate as anticoagulant. An aliquot of blood sample was diluted 200-fold with the following buffer (10mM HEPES-Na, 136mM NaCl, 2.7mM KCl, 2.0mM MgCl 2 , 1.0mM NaH 2 PO 4 , 5.0mM dextrose, 5 mg/ml BSA, 2.5mM CaCl 2 , pH 7.4) and was stained with annexin V-FITC for 15 min in the dark. PS exposure was measured as described above.
Measurement of hematocrit and hemoglobin. Four groups of male rats were given 0, 50, 250, and 1000 ppm lead acetate in drinking water for 4 weeks. At the terminal sacrifice, blood was collected from the abdominal aorta using dipotassium EDTA as anticoagulant. Hematocrit and hemoglobin content were determined using the CELL-DYN 3500 (ABBOTT, Abbott Park, IL) within 24 h.
Hematoxylin and eosin staining and Prussian blue staining of organs. Liver and spleen were obtained surgically after blood collection, weighed, and fixed with 10% formalin. The tissue specimens were cut into 4-lm thick sections and stained with hematoxylin and eosin (H&E) and ferrocyanide. After counterstaining with nuclear fast red solution, the ferrocyanide-stained slides were dehydrated and mounted. The slides were observed with bright field microscope (Olympus CX41).
Statistical Analysis
The means and SEs of means were calculated for all treatment groups. These data were subjected to one-way ANOVA followed by Duncan's multiple range test or Student's t-test to determine which means were significantly different from the control. In all cases, a p value of < 0.05 was used to determine significant differences.
RESULTS
To examine if the exposure to lead can induce PS externalization in erythrocytes, freshly isolated human erythrocytes were incubated with low concentrations of Pb 2þ (0.1-0.5lM lead acetate) or deionized water for 24 h at 37°C, and PS exposure was measured by flow cytometer. Pb 2þ treatment increased PS exposure in a concentration-and time-dependent manner, as determined by increased annexin V-FITC binding (Figs. 1A-C) . Notably, extremely low concentrations of Pb 2þ (as low as 0.1lM) could significantly induce PS exposure after a long-term incubation. Along with PS externalization, erythrocytes displayed abnormal echinocytic shapes with protruded surface as observed in confocal microscopy (Fig. 1D) . The shape changes in erythrocytes induced by Pb 2þ were further confirmed in scanning electron microscopy where normal discocytic shapes transformed into echinocytic erythrocytes and further into spherocytes progressively ( Fig. 2A) .
Shape changes from normal discocytes into spherocytes usually accompany a substantial loss of membrane surface through vesiculation and subsequent MV generation. As shown in Figures 2B and 2C , the exposure to Pb 2þ resulted in MV generation in a concentration-and time-dependent manner. In addition, generated MV also expressed PS on their outer membrane, which can be recognized and engulfed by macrophages (Willekens et al., 2005) .
PS exposure and MV generation can be mediated by the alteration in activities of aminophospholipid translocases (Chung et al., 2007; Lim et al., 2010) . We measured the activities of flippase and scramblase, representative enzymes involved in aminophospholipid translocation, after Pb 2þ treatment. As shown in Figure 3A , flippase which recovers the exposed PS into inner membrane was inhibited by Pb 2þ . However, scramblase which disrupts membrane lipid symmetry was not affected by Pb 2þ , even at high concentrations (Fig. 3B) . Flippase activity can be attenuated by the depletion of intracellular ATP (Daleke and Lyles, 2000) . Luciferin/luciferase assay demonstrated that the exposure to Pb 2þ for 24 h depleted intracellular ATP significantly (Fig.  3C) , which matched well the inhibition of flippase. Consistently, with the lack of effect on scramblase, the intracellular Ca 2þ , a trigger for scramblase activation, was not affected (Fig. 3D) .
Tissue macrophages can recognize and engulf PS-exposed erythrocytes. To investigate if the exposure to Pb 2þ could induce erythrophagocytosis, Pb 2þ -treated human erythrocytes were coincubated with THP-1 cells that had been differentiated into macrophage with PMA. As shown in Figure 4A , macrophages were attached to Pb 2þ -exposed erythrocytes. Flow cytometry analysis demonstrated more clearly that macrophages engulfed Pb 2þ -exposed erythrocytes (Fig. 4B) . PS-exposed erythrocytes could be easily sequestered from systemic blood flow by spleen and liver. The effects of Pb 2þ exposure on PS exposure and splenic sequestration of erythrocytes were examined in rats in vivo. Prior to in vivo experiments, we confirmed that Pb 2þ -induced PS exposure and MV generation were well reproduced in rat erythrocytes (Figs. 5A and B) , although rat erythrocytes were less sensitive than human erythrocytes. Significant decrease in intracellular ROLE OF PS EXPOSURE IN LEAD-ASSOCIATED ANEMIA ATP was also observed (Fig. 5C ) suggesting that Pb 2þ -induced PS exposure through ATP depletion in rat erythrocytes as in human. Consistently, with these results, the oral administration of 10 or 50 mg/kg of Pb 2þ to rats induced PS exposure ex vivo indeed (Fig. 5D) . To examine the long-term effects of Pb 2þ exposure on erythrocyte clearance, drinking water containing 0, 50, 250, and 1000 ppm lead acetate was supplied to rats subchronically for 4 weeks. Hematocrit and hemoglobin level, indicators of erythrocyte count, were significantly decreased by the exposure to Pb 2þ (Figs. 6A and B) . The relative organ weights of both liver and spleen increased significantly (Fig.  6C ). Most strikingly, Pb 2þ exposure from the doses as low as 250 ppm induced a clear sign of iron accumulation in the spleen (Fig. 6D) , indicating that Pb 2þ accelerated erythrocyte clearance through erythrophagocytosis indeed.
DISCUSSION
In the present study, we demonstrated that Pb 2þ could increase splenic sequestration of erythrocytes through PS exposure and erythrophagocytosis. Pb 2þ -induced PS exposure was mediated through the inhibition of flippase by the depletion of intracellular ATP. Abnormal shape and MV generation, other triggers for the erythrophagocytosis by macrophage, were also observed in the Pb 2þ -treated erythrocytes. We could also show that human macrophages could successfully recognize and phagocytosis lead-exposed erythrocytes. These observations were confirmed in rat in vivo through ex vivo PS exposure and iron accumulation in the spleen, suggesting that Pb 2þ -induced PS exposure in erythrocytes can provoke erythrocyte clearance and ultimately anemia.
Anemia is one of most well-known toxic health effects associated with lead exposure. Various mechanisms have been suggested for Pb 2þ -associated anemia including interference with iron transport, shortening of erythrocyte life span and inhibition of the globulin synthesis, and ribosomal RNA degradation (Ichiba et al., 1992; Kim et al., 1995) , but the impairment of heme metabolism has been regarded as a major contributing factor. Lead inhibits several enzymes participating in the heme synthesis such as ALAD and heme chelatase. Especially, ALAD is very sensitive to lead, of which IC 50 was estimated to be around 1.9lM (Davis and Avram, 1980) . Because of this sensitivity, the inhibition of ALAD and subsequent impairment of heme production is suggested to play a major role in lead-associated anemia. However, direct evidence supporting the relationship between ALAD inhibition and anemia was not provided, casting a doubt on the role of the inhibition of ALAD or heme synthesis in lead-associated anemia. Signifying this doubt, although the inhibition of ALAD is observed at very low level of BLL ranging 2.7-2.9 lg/dl (Murata et al., 2003) , anemia was reported at much higher concentrations (> 62 lg/dl). In addition, people with ALAD2 polymorphism, which has a higher affinity to lead than those with ALAD1 polymorphism, are known to exhibit lower occurrence of anemia (Sakai et al., 2000; Süzen et al., 2003) . In these reports, ALAD is suggested to work as an endogenous chelating agent for lead, detoxifying and inactivating blood lead from manifesting toxicity. Similar to ALAD, low doses of Pb 2þ (0.1-0.5lM) can induce PS exposure, shape changes, and erythrophagocytosis after an extended time of exposure in vitro. This concentration is in a proximate range to the BLL defining lead poisoning (> 10 lg/dl, 0.5lM). Most importantly, subchronic exposure to Pb 2þ through drinking water could increase PS exposure and erythrocyte clearance in vivo (Fig. 6) . These results suggest that increased clearance of erythrocytes mediated through PS exposure by lead exposure can contribute to anemia, indeed.
PS exposure on erythrocytes is a strong phagocytic signal of apoptosis to tissue macrophages. PS is recognized by various PS receptor and glycoprotein-like lactadherin, TIM-1 and TIM-4 (T-cell immunoglobulin-and mucindomaincontaining molecule). Tissue macrophages recognize and uptake this complex (Fens et al., 2008; Kobayashi et al., 2007) . Role of PS exposure and shape changes of erythrocytes in anemia was well established in disease states such as sickle cell anemia (de Jong and Kuypers, 2006; Kuypers et al., 1998; Lang et al., 2007) . Recently, we demonstrated that a drug can also induce anemia through PS exposure and subsequent erythrophagocytosis . However, there is no report concerning environmental toxicant-induced erythrophagocytosis to our best knowledge. Our study demonstrating that lead-induced PS exposure can contribute to anemia further substantiates the important role of PS exposure and subsequently increased erythrocyte clearance in the chemical-induced anemia.
Depletion of ATP is shown to underlie Pb 2þ -induced PS exposure. Pb 2þ inhibits enzymes associated with glycolysis, which provides erythrocytes with ATP (BaranowskaBosiacka and Hlynczak, 2003) . Glyceraldehyde 3-phosphate dehydrogenase (Grabowska and Gumińska, 1996) and pyruvate kinase (Paglia et al., 1975) metabolism, which might impair ATP synthesis. Nakao and his colleagues discovered decreased ATP content led morphological transformation of erythrocytes from discocytes to echinocytes (Nakao et al., 1960) . ATP sustains nonequilibrium dynamic fluctuations in the erythrocyte membrane, which is critical in the maintenance of normal biconcave shapes . Therefore, we believe that the depletion of ATP may explain lead-induced PS exposure on erythrocytes. Although Pb 2þ induced significant level of PS exposure in human erythrocytes in vitro at the low concentrations from 0.1 to 0.5lM (2-10 lg/dl), erythrophagocytosis and anemia were manifested at relatively high Pb 2þ exposure level (250-1000 ppm drinking water). With the subchronic exposure to drinking water containing 250-1000 ppm Pb 2þ , BLL could be increased up to 9.1 ± 1.7 to 22.4 ± 2.3 lg/dl (Lee et al., 2006) . The discrepancy of ''potency'' between in vitro human erythrocytes and in vivo rat study could be explained by the species difference. Rat erythrocytes were less sensitive to lead-induced PS exposure than human erythrocytes in vitro. At 2 lg/dl Pb 2þ , a significant level of PS exposure could be detected in human erythrocytes (Fig. 1B) but not in rat erythrocytes (Fig. 5A) . Only from 10 lg/dl lead, rat erythrocytes showed a significant level of PS exposure. The level of difference in potency is estimated to be more than fivefold. Considering this species difference, it is understandable that BLL of 9-22 lg/dl (with 250-1000 ppm lead-contaminated drinking water) should be required to induce lead-induced PS exposure in erythrocytes and erythrophagocytosis in rats in vivo. In the same context, however, it is plausible that human may be more sensitive to lead-induced erythrophagocytosis through PS exposure although further study is required to prove it.
In conclusion, we demonstrated that low dose lead can induce PS exposure and MV generation through ATP depletion. Most importantly, we found that subchronic exposure to lead increased erythrocyte clearance indeed. We believe that our study will provide a new insight into the role of PS exposure and erythrophagocytosis in lead-induced anemia. Values are the mean ± SEM of three to four independent experiments. *Significant differences from the control group (p < 0.05).
